These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16854935)

  • 1. Commentary: genes as instruments for evaluation of markers and causes.
    Glynn RJ
    Int J Epidemiol; 2006 Aug; 35(4):932-4. PubMed ID: 16854935
    [No Abstract]   [Full Text] [Related]  

  • 2. Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk.
    Hingorani AD; Shah T; Casas JP
    Eur Heart J; 2006 Jun; 27(11):1261-3. PubMed ID: 16684780
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary: Social class, C-reactive protein and coronary heart disease.
    Casas JP
    Int J Epidemiol; 2008 Apr; 37(2):299-300. PubMed ID: 18285367
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetically elevated C-reactive protein and vascular disease.
    Bubb MR
    N Engl J Med; 2009 Feb; 360(9):933-4; author reply 934-5. PubMed ID: 19256030
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetically elevated C-reactive protein and vascular disease.
    Morita H; Nagai R
    N Engl J Med; 2009 Feb; 360(9):934; author reply 934-5. PubMed ID: 19256031
    [No Abstract]   [Full Text] [Related]  

  • 6. Mendelian randomization suggests no causal association between C-reactive protein and carotid intima-media thickness in the young Finns study.
    Kivimäki M; Lawlor DA; Eklund C; Smith GD; Hurme M; Lehtimäki T; Viikari JS; Raitakari OT
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):978-9. PubMed ID: 17377152
    [No Abstract]   [Full Text] [Related]  

  • 7. The additive contribution from inflammatory genetic markers on the severity of cardiovascular disease.
    Berg KK; Madsen HO; Garred P; Wiseth R; Gunnes S; Videm V
    Scand J Immunol; 2009 Jan; 69(1):36-42. PubMed ID: 19140875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication].
    Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG
    Ugeskr Laeger; 2009 May; 171(21):1751-5. PubMed ID: 19492468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.
    Bernardo E; Angiolillo DJ; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C; Fernandez-Ortiz A
    Am J Cardiol; 2006 Nov; 98(9):1182-4. PubMed ID: 17056323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining risk in acute coronary syndromes using molecular medicine.
    Anwaruddin S; Askari AT; Topol EJ
    J Am Coll Cardiol; 2007 Jan; 49(3):279-89. PubMed ID: 17239708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic approaches for the investigation of genes associated with coronary heart disease.
    Kraus WE
    Am Heart J; 2000 Oct; 140(4):S27-35. PubMed ID: 11011321
    [No Abstract]   [Full Text] [Related]  

  • 12. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk.
    Hage FG; Szalai AJ
    J Am Coll Cardiol; 2007 Sep; 50(12):1115-22. PubMed ID: 17868801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arteriosclerosis and C-reactive protein gene.
    Higaki J
    Hypertens Res; 2006 May; 29(5):299. PubMed ID: 16832147
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetics of C-reactive protein: new possibilities and complications.
    Kluft C; de Maat MP
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):1956-9. PubMed ID: 14617617
    [No Abstract]   [Full Text] [Related]  

  • 15. C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain.
    Palomino-Morales R; Vazquez-Rodriguez TR; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2009 Feb; 36(2):341-6. PubMed ID: 19040303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor alleles and C-reactive protein in hemodialysis patients.
    Pacini S; Punzi T; Gulisano M; Boddi V; Aterini S; Amato M; Ruggiero M
    Ital J Anat Embryol; 2008; 113(1):55-62. PubMed ID: 18491455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study).
    Kardys I; de Maat MP; Klaver CC; Despriet DD; Uitterlinden AG; Hofman A; de Jong PT; Witteman JC
    Am J Cardiol; 2007 Aug; 100(4):646-8. PubMed ID: 17697822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on genetic testing for heart disease. It's complicated but promising. Here's what genes can tell us today.
    Harv Heart Lett; 2012 Sep; 23(1):1, 7. PubMed ID: 23101124
    [No Abstract]   [Full Text] [Related]  

  • 19. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms associated with coronary heart disease: better by the score.
    Shiffman D; Rowland CM; Sninsky JJ; Devlin JJ
    Curr Opin Mol Ther; 2006 Dec; 8(6):493-9. PubMed ID: 17243484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.